HMGB1 and cancer: In a study investigating oral squamous cell carcinoma (OSCC), it was found that extracellular HMGB1 could be overexpressed as a cancer cell growth factor and upregulate the expression of RANKL in osteoclasts by activating RAGE and TLR4 receptors.